Skip to main content

Navigation group

Type at least 3 characters
1,085 articles

Articles

Original Research

Published on 16 May 2023

Vitamin D3 alleviates nonalcoholic fatty liver disease in rats by inhibiting hepatic oxidative stress and inflammation via the SREBP-1-c/ PPARα-NF-κB/IR-S2 signaling pathway

in Gastrointestinal and Hepatic Pharmacology

  • Doha Reda
  • Gehad E. Elshopakey
  • Talat A. Albukhari
  • Samah J. Almehmadi
  • Bassem Refaat
  • Engy F. Risha
  • Hebatallah A. Mahgoub
  • Mohamed E. El-Boshy
  • Fatma M. Abdelhamid
Vitamin D3 alleviates nonalcoholic fatty liver disease in rats by inhibiting hepatic oxidative stress and inflammation via the SREBP-1-c/ PPARα-NF-κB/IR-S2 signaling pathway
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1164512
  • 6,442 views
  • 15 citations